These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21045204)

  • 1. Intracellular delivery strategies for microRNAs and potential therapies for human cardiovascular diseases.
    Shi MA; Shi GP
    Sci Signal; 2010 Nov; 3(146):pe40. PubMed ID: 21045204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.
    Calway T; Kim GH
    J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):131-43. PubMed ID: 25261390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening identifies microRNAs that target Nox2 and improve function after acute myocardial infarction.
    Yang J; Brown ME; Zhang H; Martinez M; Zhao Z; Bhutani S; Yin S; Trac D; Xi JJ; Davis ME
    Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H1002-H1012. PubMed ID: 28235791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to deliver microRNAs as potential therapeutics in the treatment of cardiovascular pathology.
    Chistiakov DA; Sobenin IA; Orekhov AN
    Drug Deliv; 2012 Nov; 19(8):392-405. PubMed ID: 23173580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-based therapeutics in cardiovascular disease: screening and delivery to the target.
    Mellis D; Caporali A
    Biochem Soc Trans; 2018 Feb; 46(1):11-21. PubMed ID: 29196609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of microRNAs in the cardiovascular system.
    Scalbert E; Bril A
    Curr Opin Pharmacol; 2008 Apr; 8(2):181-8. PubMed ID: 18243792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA nanotherapeutics for cancer.
    Ganju A; Khan S; Hafeez BB; Behrman SW; Yallapu MM; Chauhan SC; Jaggi M
    Drug Discov Today; 2017 Feb; 22(2):424-432. PubMed ID: 27815139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.
    Kwekkeboom RF; Lei Z; Doevendans PA; Musters RJ; Sluijter JP
    Clin Sci (Lond); 2014 Sep; 127(6):351-65. PubMed ID: 24895056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-viral nanocarriers for intracellular delivery of microRNA therapeutics.
    Bai Z; Wei J; Yu C; Han X; Qin X; Zhang C; Liao W; Li L; Huang W
    J Mater Chem B; 2019 Feb; 7(8):1209-1225. PubMed ID: 32255160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting microRNA expression to regulate angiogenesis.
    Kuehbacher A; Urbich C; Dimmeler S
    Trends Pharmacol Sci; 2008 Jan; 29(1):12-5. PubMed ID: 18068232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNAs in Cardiovascular Disease: Small Molecules but Big Roles.
    Yan B; Wang H; Tan Y; Fu W
    Curr Top Med Chem; 2019; 19(21):1918-1947. PubMed ID: 31393249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as therapeutics for future drug delivery systems in treatment of lung diseases.
    Dua K; Hansbro NG; Foster PS; Hansbro PM
    Drug Deliv Transl Res; 2017 Feb; 7(1):168-178. PubMed ID: 27848224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in cardiovascular disease: an introduction for clinicians.
    Romaine SP; Tomaszewski M; Condorelli G; Samani NJ
    Heart; 2015 Jun; 101(12):921-8. PubMed ID: 25814653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE(-/-) Mice.
    Kheirolomoom A; Kim CW; Seo JW; Kumar S; Son DJ; Gagnon MK; Ingham ES; Ferrara KW; Jo H
    ACS Nano; 2015 Sep; 9(9):8885-97. PubMed ID: 26308181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs.
    Mullick Chowdhury S; Wang TY; Bachawal S; Devulapally R; Choe JW; Abou Elkacem L; Yakub BK; Wang DS; Tian L; Paulmurugan R; Willmann JK
    J Control Release; 2016 Sep; 238():272-280. PubMed ID: 27503707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA therapy targeting cancer stem cells: a new paradigm for cancer treatment and prevention of tumor recurrence.
    Osaki M; Okada F; Ochiya T
    Ther Deliv; 2015 Mar; 6(3):323-37. PubMed ID: 25853308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs: role in cardiovascular biology and disease.
    Zhang C
    Clin Sci (Lond); 2008 Jun; 114(12):699-706. PubMed ID: 18474027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.
    Bernardo BC; Ooi JY; Lin RC; McMullen JR
    Future Med Chem; 2015; 7(13):1771-92. PubMed ID: 26399457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.
    Nguyen MA; Wyatt H; Susser L; Geoffrion M; Rasheed A; Duchez AC; Cottee ML; Afolayan E; Farah E; Kahiel Z; Côté M; Gadde S; Rayner KJ
    ACS Nano; 2019 Jun; 13(6):6491-6505. PubMed ID: 31125197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of therapeutic miRNA using polymer-based formulation.
    Ban E; Kwon TH; Kim A
    Drug Deliv Transl Res; 2019 Dec; 9(6):1043-1056. PubMed ID: 31049843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.